用经支气管镜单向活瓣置入肺减容术治疗COPD的研究进展

Progress in the treatment of COPD by transbronchoscopic one-way valve implantation

慢性阻塞性肺疾病(COPD)是一种常见的慢性疾病。此病患者的主要临床表现为慢性支气管炎、肺气肿、持续性呼吸气流受限、肺功能进行性减退等,其生活质量可受到严重的影响。肺气肿是COPD患者最主要的病理改变之一。近年来,经支气管镜单向活瓣(FBV)置入肺减容术在治疗重度肺气肿方面得到了广泛的应用。本文就经支气管镜FBV置入肺减容术的临床应用情况作一综述。

Chronic obstructive pulmonary disease(COPD)is a common chronic disease.The main clinical manifestations of patients with this disease are chronic bronchitis,emphysema,persistent respiratory airflow restriction,progressive decline of lung function,etc.,and their quality of life can be seriously affected.Emphysema is one of the most important pathological changes in COPD patients.In recent years,bronchoscopic one-way valve(EBV)implantation has been widely used in the treatment of severe emphysema.This article reviews the clinical application of bronchoscopic EBV implantation for lung volume reduction.